Protective effect of adenosine triphosphate and benidipine separately or together against cardiotoxicity caused by bevacizumab

References

• Aziz M, Abd El Fattah MA, Ahmed KA, Moawad H. 2019. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats. Can J Physiol Pharmacol. 98:183–193. doi:10.1139/cjpp-2019-0299
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M. 2002. Theory and practice of histological techniques. 5th ed. London: Churchill Livingstone; p. 173–185.
   Google Scholar
• Bordun KA, Premecz S, daSilva M, Mandal S, Goyal V, Glavinovic T, Cheung M, Cheung D, White CW, Chaudhary R, Freed DH, Villarraga HR, Herrmann J, Kohli M, Ravandi A, Thliveris J, Pitz M, Singal PK, Mulvagh S, Jassal DS. 2015. The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity. Am J Physiol Heart Circ Physiol. 309:692–701. doi:10.1152/ajpheart.00172.2015
   PubMed Web of Science ®Google Scholar
• Bulanova E, Bulfone-Paus S. 2010. P2 receptor-mediated signaling in mast cell biology. Purinerg Sign. 6:3–17. doi:10.1007/s11302-009-9173-z
   PubMed Web of Science ®Google Scholar
• Cehofski LJ, Kruse A, Alsing AN, Nielsen JE, Pedersen S, Kirkeby S, Honoré B, Vorum H. 2018. Intravitreal bevacizumab up-regulates transthyretin in experimental branch retinal vein occlusion. Mol Vis. 24:759–766.
   PubMed Web of Science ®Google Scholar
• Chiang B, Essick E, Ehringer W, Murphree S, Hauck MA, Li M, Chien S. 2007. Enhancing skin wound healing by direct delivery of intracellular adenosine triphosphate. Am J Surg. 193:213–218. doi:10.1016/j.amjsurg.2006.08.069
   PubMed Web of Science ®Google Scholar
• Faivre S, Demetri G, Sargent W, Raymond E. 2007. Molecular basis for sunitinib efficacy and future clinical development. Nat Rev Drug Discov. 6:734–745. doi:10.1038/nrd2380
   PubMed Web of Science ®Google Scholar
• Ferrara N, Hillan KJ, Gerber HP, Novotny W. 2004. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 3:391–400. doi:10.1038/nrd1381
   PubMed Web of Science ®Google Scholar
• Guo D, Wang Q, Li C, Wang Y, Chen X. 2017. VEGF stimulated the angiogenesis by promoting the mitochondrial functions. Oncotarget. 8:77020–77027. doi:10.18632/oncotarget.20331
   PubMedGoogle Scholar
• Hassan MQ, Akhtar MS, Akhtar M, Ali J, Haque SE, Najmi AK. 2016. Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damage. Ther Adv Cardiovasc Dis. 10:214–223. doi:10.1177/1753944716630653
   PubMedGoogle Scholar
• Kumbasar S, Cetin N, Yapca OE, Sener E, Isaoglu U, Yilmaz M, Salman S, Aksoy AN, Gul MA, Suleyman H. 2014. Exogenous ATP administration prevents ischemia/reperfusion-induced oxidative stress and tissue injury by modulation of hypoxanthine metabolic pathway in rat ovary. Ciência Rural. 44:1257–1263. doi:10.1590/0103-8478cr20131006
   Web of Science ®Google Scholar
• McCord JM. 1985. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 312:159–163. doi:10.1056/NEJM198501173120305
   PubMed Web of Science ®Google Scholar
• Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. 2005. Systemic bevacizumab (avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 112:1035–1047. doi:10.1016/j.ophtha.2005.02.007
   PubMed Web of Science ®Google Scholar
• Mozolevska V, Schwartz A, Cheung D, Goyal V, Shaikh B, Dingman B, Kim E, Mittal I, Asselin CY, Edel A, Ravandi A, Thliveris J, Singal PK, Czaykowski P, Jassal DS. 2019. Role of renin-angiotensin system antagonists in the prevention of bevacizumab and sunitinib mediated cardiac dysfunction. Am J Physiol Heart Circ Physiol. 316:446–458. doi:10.1152/ajpheart.00344.2018
   Web of Science ®Google Scholar
• Ng R, Better N, Green MD. 2006. Anticancer agents and cardiotoxicity. Sem Oncol. 33:2–14. doi:10.1053/j.seminoncol.2005.11.001
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358. doi:10.1016/0003-2697(79)90738-3
   PubMed Web of Science ®Google Scholar
• Ohtani K, Usui S, Kaneko S, Takashima S, Kitano K, Yamamoto K, Okajima M, Furusho H, Takamura M. 2012. Benidipine reduces ischemia reperfusion-induced systemic oxidative stress through suppression of aldosterone production in mice. Hypertens Res. 35:287–294. doi:10.1038/hr.2011.183
   PubMed Web of Science ®Google Scholar
• Orrenius S, Burkitt MJ, Kass GE, Dypbukt JM, Nicotera P. 1992. Calcium ions and oxidative cell injury. Ann Neurol. 32 Suppl:33–42. doi:10.1002/ana.410320708
   Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 25:192–205. doi:10.1016/0003-2697(68)90092-4
   PubMed Web of Science ®Google Scholar
• Sheu SJ, Chao YM, Liu NC, Chan JY. 2015. Differential effects of bevacizumab, ranibizumab and aflibercept on cell viability, phagocytosis and mitochondrial bioenergetics of retinal pigment epithelial cell. Acta Ophthalmol. 93:631–643. doi:10.1111/aos.12745
   Web of Science ®Google Scholar
• Touyz RM, Herrmann J. 2018. Cardiotoxicity with vascular endothelial growth factor inhibitor therapy. Nat Publ Group Precis Oncol. 13:1–11. doi:10.1038/s41698-018-0056-z
   Google Scholar
• Virani SA, Dent S, Brezden-Masley C, Clarke B, Davis MK, Jassal DS, Johnson C, Lemieux J, Paterson I, Sebag IA, Simmons C, Sulpher J, Thain K, Thavendiranathan P, Wentzell JR, Wurtele N, Côté MA, Fine NM, Haddad H, Hayley BD, Hopkins S, Joy AA, Rayson D, Stadnick E, Straatman L. 2016. Canadian cardiovascular society guidelines for evaluation and management of cardiovascular complications of cancer therapy. Can J Cardiol. 32:831–841. doi:10.1016/j.cjca.2016.02.078
   PubMed Web of Science ®Google Scholar
• Zhou R, Xu Q, Zheng P, Yan L, Zheng J, Dai G. 2008. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur J Pharmacol. 586:244–250. doi:10.1016/j.ejphar.2008.02.057
   PubMed Web of Science ®Google Scholar